Tolazamide

Table of contents

  • Brand Names
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Pregnancy and Lactation Implications
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Genes that may be involved
  • Drug Interactions
  • Nutrition/Nutraceutical Interactions
  • Dosage
  • Pharmacokinetics and Pharmacodynamics
  • Special Considerations

Brand Names

North America

USA: Tolazamide

Drug combinations

Chemistry

Tolazamide: C~14~H~21~N~3~O~3~S. Mw: 311.40. (1) Benzenesulfonamide, N-[[(hexahydro-1H-azepin-1-yl)amino]carbonyl]-4-methyl-; (2) 1-(Hexahydro-1H-azepin-1-yl)-3-(p-tolylsulfonyl)urea. CAS-1156-19-0 (1964).

Pharmacologic Category

Antidiabetic Agents; Sulfonylureas. (ATC-Code: A10BB05).

Mechanism of action

Stimulates insulin release from pancreatic β-cells. Reduces glucose output from liver. Insulin sensitivity increased at peripheral target sites.

Therapeutic use

Adjunct to diet for management of mild-to-moderately severe, stable, type 2 diabetes mellitus (non-insulin-dependent).

Pregnancy and lactiation implications

Adverse events observed in animal studies. Use of oral agents generally not recommended as routine management of gestational diabetes mellitus or type 2 diabetes mellitus during pregnancy. Insulin is drug of choice for control of diabetes mellitus during pregnancy. Excretion in breast milk unknown (not recommended in nursing women).

Unlabeled use

Contraindications

Hypersensitivity to tolazamide, sulfonylureas, or any component of the formulation. Type 1 diabetes mellitus (insulin-dependent) therapy. Diabetic ketoacidosis.

Warnings and precautions

All sulfonylurea drugs capable of producing severe hypoglycemia (use with caution). Oral hypoglycemic drugs may be associated with increased cardiovascular mortality. It may be necessary to discontinue therapy and administer insulin if patient is exposed to stress (fever, trauma, infection, surgery). Chemical similarities are present among sulfonamides, sulfonylureas, carbonic anhydrase inhibitors, thiazides, loop diuretics (except ethacrynic acid). Use in sulfonylurea allergy contraindicated. However, risk of cross-reaction exists in allergy to any of these compounds (avoid use when previous reaction severe).

Information

Legal

Legal Notice
Privacy Policy
Cookie Policy

Contact

Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart